Cardiovascular disease prevention in patients with type 2 diabetes: The role of oral anti-diabetic agents.
about
Importance of hepatitis C virus-associated insulin resistance: therapeutic strategies for insulin sensitizationCardiovascular impact of drugs used in the treatment of diabetesAntidiabetic effects of Corni Fructus extract in streptozotocin-induced diabetic ratsCardiovascular benefits and safety profile of acarbose therapy in prediabetes and established type 2 diabetesIntensification of oxidative stress and inflammation in type 2 diabetes despite antihyperglycemic treatment.American ginseng berry juice intake reduces blood glucose and body weight in ob/ob mice.Association of hypoglycemic treatment regimens with cardiovascular outcomes in overweight and obese subjects with type 2 diabetes: a substudy of the SCOUT trialMental stress assessment using simultaneous measurement of EEG and fNIRS.Hepatitis C virus induced insulin resistance impairs response to anti viral therapy.Thiazolidinedione drugs in the treatment of type 2 diabetes mellitus: past, present and future.Psoralea corylifolia L. Seed Extract Attenuates Diabetic Nephropathy by Inhibiting Renal Fibrosis and Apoptosis in Streptozotocin-Induced Diabetic Mice.Effects of metformin on blood and urine pro-inflammatory mediators in patients with type 2 diabetes.Confusion over thiazolidinedione-induced heart failure: need for a better definition of heart failure.Pioglitazone attenuates cardiac fibrosis and hypertrophy in a rat model of diabetic nephropathy.Liraglutide and Metformin alone or combined therapy for type 2 diabetes patients complicated with coronary artery disease.Developing a metformin prescribing tool for use in adults with mental illness to reduce medication-related weight gain and cardiovascular risk.Metformin-induced activation of AMPK inhibits the proliferation and migration of human aortic smooth muscle cells through upregulation of p53 and IFI16.Effects of Syzygium aromaticum-derived oleanolic acid on glucose transport and glycogen synthesis in the rat small intestine.Statistical methods for active pharmacovigilance, with applications to diabetes drugs.
P2860
Q33812148-B6A21B90-9338-4670-B3A7-1D533325DDD2Q34383575-F25DA34F-6CB6-481F-8A1A-DDFEF7664D6FQ36053411-6E5B2310-CC75-4E5C-A8C6-104DA55BFEF4Q36088468-3A867632-722C-461E-9C38-34AEC652EA5EQ36739732-E036A8D9-BFBE-4E1A-BAA6-09FB69762C26Q37136042-68AADCAE-5D39-4EBE-8777-6AA26FD1B514Q37277912-DB3E1227-C0E1-4A91-A9F9-499B2266CF9FQ37404388-7030895D-D73E-4FD3-9959-5BB17A23AE4DQ37980432-0D3272FF-9EA8-40C5-8D1A-C420E81A274AQ38641190-294A6221-FF51-47EC-AFE0-DAFF85A5B1BFQ41583942-307AE981-C6D8-4CB3-BB78-2E14B8472FB7Q42363819-590D63F0-0311-47D7-ACEC-10F26CB3BB19Q46569270-8E1B9D61-942D-4970-95E9-ED3EF3E59D99Q46705414-EA215BA2-13C1-4F44-B06C-A811BFD6FCDFQ47119201-46642153-7820-478F-9CB5-7C90037E58C4Q47197810-5FCEECA1-3831-4835-ACFB-9B90A0ACFEF4Q47246258-3FD8569E-FB72-4BD2-826A-721C6E51877DQ47268877-9975C638-5EE9-4A3A-9486-D49C6389E4F6Q51097460-445C0869-7C65-44AA-990F-427523CC8DE5
P2860
Cardiovascular disease prevention in patients with type 2 diabetes: The role of oral anti-diabetic agents.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Cardiovascular disease prevent ...... of oral anti-diabetic agents.
@ast
Cardiovascular disease prevent ...... of oral anti-diabetic agents.
@en
type
label
Cardiovascular disease prevent ...... of oral anti-diabetic agents.
@ast
Cardiovascular disease prevent ...... of oral anti-diabetic agents.
@en
prefLabel
Cardiovascular disease prevent ...... of oral anti-diabetic agents.
@ast
Cardiovascular disease prevent ...... of oral anti-diabetic agents.
@en
P2860
P356
P1476
Cardiovascular disease prevent ...... of oral anti-diabetic agents.
@en
P2093
Peter J Grant
Ramzi A Ajjan
P2860
P304
P356
10.3132/DVDR.2006.023
P407
P577
2006-12-01T00:00:00Z